Education
About Us
Working with TipRanks
Follow Us
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
KREBSBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹63.55 - ₹129.00
Previous CloseN/A
Volume3.29K
Average Volume (3M)3.62K
Market Cap
₹1.77B
Enterprise Value₹3.95B
Total Cash (Recent Filing)₹3.38M
Total Debt (Recent Filing)₹2.12B
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.83
Shares Outstanding21,560,587
10 Day Avg. Volume404
30 Day Avg. Volume3,621
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)-1.25
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
KREBSBIO FAQ
What was Krebs Biochemicals & Industries Ltd.’s price range in the past 12 months?
Krebs Biochemicals & Industries Ltd. lowest stock price was ₹63.55 and its highest was ₹129.00 in the past 12 months.
What is Krebs Biochemicals & Industries Ltd.’s market cap?
Krebs Biochemicals & Industries Ltd.’s market cap is ₹1.77B.
When is Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date?
Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date is Aug 06, 2025 which is in 22 days.
How were Krebs Biochemicals & Industries Ltd.’s earnings last quarter?
Krebs Biochemicals & Industries Ltd. released its earnings results on May 20, 2025. The company reported -₹3.83 earnings per share for the quarter, missing the consensus estimate of N/A by -₹3.83.
Is Krebs Biochemicals & Industries Ltd. overvalued?
According to Wall Street analysts Krebs Biochemicals & Industries Ltd.’s price is currently Overvalued.
Does Krebs Biochemicals & Industries Ltd. pay dividends?
Krebs Biochemicals & Industries Ltd. does not currently pay dividends.
What is Krebs Biochemicals & Industries Ltd.’s EPS estimate?
Krebs Biochemicals & Industries Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krebs Biochemicals & Industries Ltd. have?
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding.
What happened to Krebs Biochemicals & Industries Ltd.’s price movement after its last earnings report?
Krebs Biochemicals & Industries Ltd. reported an EPS of -₹3.83 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.191%.
Which hedge fund is a major shareholder of Krebs Biochemicals & Industries Ltd.?
Currently, no hedge funds are holding shares in IN:KREBSBIO
Company Description
Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.
Technical Analysis
Aarey Drugs & Pharmaceuticals Ltd.
―
Bafna Pharmaceuticals Limited
―
Bal Pharma Limited
―
Vaishali Pharma Ltd.
―